Leonard S. Schleifer

2014

In 2014, Leonard S. Schleifer earned a total compensation of $42M as President and Chief Executive Officer at Regeneron Pharmaceuticals, a 16% increase compared to previous year.

Compensation breakdown

Bonus$2,142,400
Option Awards$38,644,700
Salary$1,071,200
Other$107,124
Total$41,965,424

Schleifer received $38.6M in option awards, accounting for 92.09% of the total pay in 2014.

Schleifer also received $2.1M in bonus, $1.1M in salary and $107.1K in other compensation.

Rankings

In 2014, Leonard S. Schleifer's compensation ranked 27th out of 12,997 executives tracked by ExecPay. In other words, Schleifer earned more than 99.8% of executives.

ClassificationRankingPercentile
All
27
out of 12,997
100th
Division
Manufacturing
8
out of 4,966
100th
Major group
Chemicals And Allied Products
2
out of 1,653
100th
Industry group
Drugs
2
out of 1,327
100th
Industry
Pharmaceutical Preparations
2
out of 1,017
100th
Source: SEC filing on April 26, 2016.

Schleifer's colleagues

We found four more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2014.

2014

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

2014

Neil Stahl

Regeneron Pharmaceuticals

Executive Vice President, Research & Development

2014

Robert Terifay

Regeneron Pharmaceuticals

Executive Vice President, Commercial

2014

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like